This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Fumitaka Ito: Innovator in Cardiovascular Treatments
Introduction
Fumitaka Ito is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the synthesis of alkaloids that have potential applications in treating cardiovascular illnesses. His work exemplifies the intersection of innovation and healthcare.
Latest Patents
Fumitaka Ito holds a patent for the "Synthesis of indolizidines related to the carditonic pumiliotoxin a." This patent describes a method for creating dendrobatid alkaloids with specific chemical formulas. The alkaloids produced through this method are intended for use in treating cardiovascular diseases, showcasing the potential impact of his research on medical treatments.
Career Highlights
Ito is affiliated with the University of California, where he has been involved in various research projects. His academic background and research focus have allowed him to explore innovative solutions in the field of pharmacology. His work has garnered attention for its potential to improve health outcomes.
Collaborations
Fumitaka Ito has collaborated with Larry Eugene Overman, a fellow researcher in the field. Their partnership has contributed to advancements in the synthesis of complex organic compounds, further enhancing the potential applications of their research.
Conclusion
Fumitaka Ito's contributions to the synthesis of alkaloids represent a significant advancement in the field of cardiovascular treatment. His innovative approach and collaboration with other experts highlight the importance of research in developing new medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
